Given the challenges of symptom management during hospice care, patients require responsive opioid prescribing. Within the context of the national opioid crisis, medication diversion in hospice is an increasing concern.1
We conducted a national survey of hospices (June-September 2018). Using 2015 data on US hospices,2 we randomly selected 600 agencies, proportionately stratified by state and profit status. We surveyed agency representatives by phone or online about practices, policies, and experiences regarding medication diversion. Procedures were deemed exempt by the University of Maryland, Baltimore, institutional review board. Survey participation implied informed consent.
Cagle JG, McPherson ML, Frey JJ, et al. Estimates of Medication Diversion in Hospice. JAMA. 2020;323(6):566–568. doi:10.1001/jama.2019.20388
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: